10x Genomics
231 hedge funds and large institutions have $2.45B invested in 10x Genomics in 2022 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 83 increasing their positions, 79 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
20% less call options, than puts
Call options by funds: $6.44M | Put options by funds: $8.05M
37% less capital invested
Capital invested by funds: $3.91B → $2.45B (-$1.46B)
39% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 54
Holders
231
Holding in Top 10
7
Calls
$6.44M
Puts
$8.05M
Top Buyers
| 1 | +$43.6M | |
| 2 | +$28.8M | |
| 3 | +$28.6M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$27.7M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$22.6M |
Top Sellers
| 1 | -$70.7M | |
| 2 | -$56.5M | |
| 3 | -$49.3M | |
| 4 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$23.2M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$15.5M |